Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Akebia Therapeutics, Inc. (Nasdaq: AKBA) has announced that CEO John Butler will present virtually at the H.C. Wainwright 24th Annual Global Investment Conference, scheduled for September 12–14, 2022. This hybrid conference will feature the presentation available on-demand starting September 12 for 90 days via the Investors section of Akebia's website. Akebia aims to improve the lives of those affected by kidney disease and has been operational since its founding in 2007 in Cambridge, Massachusetts.

CAMBRIDGE, Mass., Sept. 1, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present virtually at the H.C. Wainwright 24^th Annual Global Investment Conference. The hybrid conference will take place September 12–14, 2022.  

The presentation will be available on-demand beginning September 12, 2022 through the Investors section of Akebia's website at https://ir.akebia.com for approximately 90 days. 

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-virtually-at-the-hc-wainwright-24th-annual-global-investment-conference-301615782.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics present at the H.C. Wainwright 24th Annual Global Investment Conference?

Akebia Therapeutics will present virtually at the conference from September 12 to 14, 2022.

Where can I watch Akebia's presentation from the conference?

The presentation will be available on-demand starting September 12, 2022, on Akebia's Investors section of their website.

What is the main focus of Akebia Therapeutics?

Akebia Therapeutics is focused on developing therapeutics to improve the lives of people impacted by kidney disease.

How long will Akebia's conference presentation be available for viewing?

The presentation will be available for approximately 90 days after it goes live.

What is the ticker symbol for Akebia Therapeutics?

The ticker symbol for Akebia Therapeutics is AKBA.